Summary
In rubella-infected BHK-21/13 S cell cultures new virus particles were first detected by infectivity and HA tests at 8–10 hours. Virus-specific antigen was demonstrated as early as 8 hours by PA, 12 hours by CF and immunofluorescence and 18 hours by immunodiffusion tests. Soluble (S) rubella antigen was first detectable in the medium at 15 hours using PA.
Rubella S antigen sedimented at 3.5–4 S. When mixed with 7 S rubella antibody it formed soluble immune complexes that could be detected by PA either directly or after addition of antigen or antibody. The size of the complexes, 10 to 25 S, depended on the antigen/antibody ratio.
Purified high titer rubella virus had both PA and CF antigen activity. The ratios of HA/PA/CF antigen titers were about 1000/5/1 with convalescent rubella sera. The serum titers with virion antigen were higher than those with S antigen.
Degradation of virus particles with Tween 80 and ether or nonionic detergents gave components with biological activity (HA, PA, CF). Degradation of virus altered its PA and CF box titration pattern to that typical of rubella S antigen. Red cell absorption removed 99% of the HA activity of degraded virus, but a large fraction of the PA and CF antigenicity remained unabsorbed. Absorption of S antigen with erythrocytes did not detectably decrease PA or CF antigenicity.
Nonidet P 40-treated virus was separated in glycerol gradients into a slowly sedimenting fraction with HA, PA and CF activity and a 150 S ribonucleoprotein fraction with PA and CF activity. The sedimentation of HA subunits was very heterogeneous in the absence of detergents. Sedimentation was more homogeneous and recovery of antigen better in gradients containing 0.1% Nonidet P 40 and 0.5 M urea. Detergent-degraded virus was fractionated by combination of red cell absorption and sedimentation into a slow (or) light fraction, with some HA and PA activity, a sharp peak of PA at 3 to 4 S and a fast fraction with most HA and some PA activity. It appears that the major determinant of rubella S antigen is a subunit of the rubella virus envelope.
Similar content being viewed by others
References
Furukawa, T., A. Vaheri, andS. A. Plotkin: Growth of rubella virus in BHK-21 cells. III. Production of complement-fixing antigens. Proc. Soc. exp. Biol. (N.Y.)125, 1098–1102 (1967).
Schmidt, N. J., E. H. Lennette, andJ. Dennis: Density gradient centrifugation studies on rubella complement-fixing antigens. J. Immunol.99, 399–405 (1967).
Schmidt, N. J., E. H. Lennette, P. S. Gee, andJ. Dennis: Physical and Immunologic properties of rubella antigens. J. Immunol.100, 851–857 (1968).
Schmidt, N. J., andB. Styk: Immunodiffusion reactions with rubella antigens. J. Immunol.101, 210–216 (1968).
Salmi, A.: Acta path, microbiol. scand.76, 271–278 (1969).
Le Bouvier, G. L.: Physiochemical characteristics of rubella antigens theta and iota. Nature (Lond.)221, 78–79 (1969).
Penttinen, K., andG. Myllylä: Interaction of human blood platelets, viruses and antibodies. I. Platelet aggregation test with microequipment. Ann. Med. exp. Fenn.46, 188–192 (1968).
Myllylä, G., A. Vaheri, T. Vesikari, andK. Penttinen: Interaction between human blood platelets, viruses and antibodies. IV. Clin. exp. Immunol.4, 323–332 (1969).
Penttinen, K., P. Saikku, G. Myllylä, M. Brummer-Korvenkontio, andN. Oker-Blom: The platelet aggregation test in group B arbovirus infections. J. Hyg. (Lond.)68, 71–76 (1970).
Penttinen, K., L. Kääriäinen, andG. Myllylä: Cytomegalovirus antibody assay by platelet aggregation. Arch. ges. Virusforsch.29, 189–194 (1970).
Palosuo, T., K. Penttinen, andG. Myllylä: Platelet aggregation by herpes simplex antigen-antibody complexes. Arch. ges. Virusforsch.30, 11–17 (1970).
Vaheri, A., W. D. Sedwick, S. A. Plotkin, andR. Maes: Cytopathic effect of rubella virus in BHK-21 cells and growth to high titers in suspension culture. Virology27, 239–241 (1965).
Vaheri, A., W. D. Sedwick, andS. A. Plotkin: Growth of rubella virus in BHK-21 cells. I. Production, assay, and adaptation of virus. Proc. Soc. exp. Biol. (N.Y.)125, 1086–1092 (1967).
Vaheri, A., C-H. von Bonsdorff, T. Vesikari, T. Hovi, andP. Väänänen: Purification of rubella virus particles. J. gen. Virol.5, 39–46 (1969).
Hovi, T., andA. Vaheri: Infectivity and some physiochemical characteristics of rubella virus ribonucleic acid. Virology,42, 1–8 (1970).
Vesikari, T., A. Vaheri, andP. Leinikki: Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus. Arch. ges. Virusforschung35, 25–37 (1971).
Murphy, F. A., andP. H. Coleman: California group arboviruses: immunodiffusion studies. J. Immunol.99, 276–284 (1967).
Vesikari, T., andA. Vaheri: Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Brit. med. J.1, 221–223 (1968).
McEwen, C. R.: Tables for estimating sedimentation through linear concentration gradients of sucrose solution. Anal. Biochem.20, 114–119 (1967).
Norrby, E.: Separation of measles virus components by equilibrium centrifugation in CsCl gradients. I. Crude and Tween and ether treated concentrated tissue culture material. Arch. ges. Virusforsch.14, 306–318 (1964).
Holmes, I. H., andM. F. Warburton: Is rubella an arbovirus? Lancet2, 1233–1236 (1967).
von Bonsdorff, C-H., andA. Vaheri: Growth of rubella virus in BHK-21 cells: Electron microscopy of morphogenesis. J. gen. Virol.5, 47–51 (1969).
Vaheri, A., T. Vesikari, K. Penttinen, andG. Myllylä: Symposia series in immunobiological standardization international symposium on rubella vaccines, London 1968. Soluble rubella antigens, platelet aggregation and post-rubella thrombocytopenia.11, 107–108 Basel/New York:Karger, 1969.
Penttinen, K., G. Myllylä, andA. Vaheri: Soluble antigen-antibody complexes and platelet aggregation. Acta path. microbiol. scand.77, 309–317 (1969).
Laufs, R., andR. Thomssen: Eigenschaften eines mit Tween 80 und Äthyläther behandelten Rubellavirus-Hämagglutinins. Arch. ges. Virusforsch.24, 164–180 (1968).
Webster, R. G., andR. W. Darlington: Disruption of myxoviruses with Tween 20 and isolation of biologically active hemagglutinin and neuraminidase subunits. J. Virol.4, 182–187 (1969).
Numazaki, Y., andD. T. Karzon: Soluble antigen of measles virus. J. Immunol.97, 470–476 (1966).
Neurath, A. R., T. J. Wiktor, andH. Koprowski: Density gradient centrifugation studies on rabies virus. J. Bact.92, 102–106 (1966).
Vaheri, A., A. Salmi, andT. Vesikari: Antigens of rubella virions and virus specific soluble components in rubella infected BHK-21 cells. Scand. J. clin. Lab. Invest.25, Suppl. 113, 104 (1970).
Furukawa, T., S. Plotkin, D. Sedwick, andM. Profeta: Haemagglutinin of rubella virus. Nature (Lond.)215, 172–173 (1967).
Suganuma, M., S. Kohno, M. Kohase, andY. Shimizu: Occurence of rubella virus lacking hemagglutinating activity. Arch. ges. Virusforsch.29, 263–266 (1970).
Singer, S. J., andD. H. Campbell: Physical chemical studies on soluble antigen-antibody complexes. I. The valence of precipitating rabbit antibody. J. Amer. chem. Soc.74, 1794–1802 (1952).
Almeida, J. D., andA. P. Waterson: Immune complexes in hepatitis. Lancet2, 983–986 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaheri, A., Vesikari, T. Small size rubella virus antigens and soluble immune complexes: Analysis by the platelet aggregation technique. Archiv f Virusforschung 35, 10–24 (1971). https://doi.org/10.1007/BF01249748
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01249748